{"Name":"InteKrin","perma":"interkrin","BasicInfo":{"funded":"2005-01-01","isClosed":false,"closed":null,"short":"InteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders."},"FundingRounds":[{"funding_type":"venture","series":null,"announcedDate":"2010-06-14","moneyRaised":2292809},{"funding_type":"venture","series":null,"announcedDate":"2009-04-02","moneyRaised":21391923},{"funding_type":"venture","series":"c","announcedDate":"2008-08-04","moneyRaised":18500000},{"funding_type":"venture","series":"B","announcedDate":"2007-01-12","moneyRaised":23000000}],"Acquisitions":[],"AcquiredBy":{"price":5000000,"paymentType":"cash_and_stock","announcedDate":"2014-02-12","completedDate":"2014-02-12","acquisitionType":null,"acquirer":"Coherus Biosciences"},"IPO":null,"Investments":[],"Products":[],"ProductsPermas":[],"CurrentTeam":[],"PastTeam":[{"title":"Chief Business Officer","started":"2009-07-01","ended":"2010-07-01","firstName":"Geoffrey","lastName":"Parker"},{"title":"Chief Medical Officer","started":"1997-01-01","ended":null,"firstName":"Alex","lastName":"DePaoli"}]}
